Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov 1;16(1):e2024080.
doi: 10.4084/MJHID.2024.080. eCollection 2024.

Older Adults with Ph Negative Acute Lymphoblastic Leukemia: A Monocentric Experience on 57 Patients Focusing on Treatment Intensity and Age-Related Prognosis

Erika Borlenghi #  1 , Tatiana Zollner #  1 , Giuseppe Rossi  1 , Chiara Pagani  1 , Chiara Cattaneo  1 , Michele Malagola  2 , Alessandra Sottini  3 , Diego Bertoli  3 , Mariella Tonelli  4 , Marco Chiarini  3 , Rossella Leopaldo  1 , Angela Passi  1 , Lorenzo Masina  1 , Francesca Federico  1 , Carlotta Giupponi  3 , Alessandra Tucci  1
Affiliations

Older Adults with Ph Negative Acute Lymphoblastic Leukemia: A Monocentric Experience on 57 Patients Focusing on Treatment Intensity and Age-Related Prognosis

Erika Borlenghi et al. Mediterr J Hematol Infect Dis. .
No abstract available

Keywords: Acute Lymphoblastic Leukemia; Elderly patients; Intensive treatment; Ph negative.

PubMed Disclaimer

Conflict of interest statement

Competing interests: The authors declare no conflict of Interest.

Figures

Figure 1
Figure 1
Flow diagram of all patients > 55 years with ALL diagnosis and treatment really received Abbreviations: ALL: Acute Lymphoblastic Leukemia; pts: patients; neg: negative; pos: positive; Intens-treat: intensive treatment; BSC: best supportive care; Allo: allogeneic; Auto: Autologous; SCT; stem cell transplantation
Figure 2
Figure 2
Overall Survival. a) in the whole population; b) in the whole population according to age; c) in the whole population according to treatment; d) in intensively treated patients, according to age. Abbreviations: pts: patients; BSC: best supportive care; intens-treatm: intensive treatment, y: years.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Guru Murthy GS, Venkitachalam R, Mehta P. Trends in survival outcomes of B-lineage acute lymphoblastic leukemia in elderly patients: analysis of Surveillance, Epidemiology, and End Results database. Leuk Lymphoma. 2015;56:2296–2300. doi: 10.3109/10428194.2014.991921. - DOI - PubMed
    1. Gökbuget N, Boissel N, Chiaretti S, Dombret H, Doubek M, Fielding A, Foà R, Giebel S, Hoelzer D, Hunault M, Marks DI, Martinelli G, Ottmann O, Rijneveld A, Rousselot P, Ribera J, Bassan R. Management of ALL in adults: 2024 ELN recommendations from a European expert panel. Blood. 2024;143(19):1903–30. doi: 10.1182/blood.2023023568. - DOI - PubMed
    1. Aldoss I, Forman SJ, Pullarkat V. Acute Lymphoblastic Leukemia in the Older Adult. J Oncol Pract. 2019;15:67–75. doi: 10.1200/JOP.18.00271. - DOI - PubMed
    1. Bassan R, Spinelli O, Oldani E, Intermesoli T, Tosi M, Peruta B, Rossi G, Borlenghi E, Pogliani EM, Terruzzi E, Fabris P, Cassibba V, Lambertenghi-Deliliers G, Cortelezzi A, Bosi A, Gianfaldoni G, Ciceri F, Bernardi M, Gallamini A, Mattei D, Di Bona E, Romani C, Scattolin AM, Barbui T, Rambaldi A. Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL) Blood. 2009;113(18):4153–62. doi: 10.1182/blood-2008-11-185132. - DOI - PubMed
    1. Bassan R, Pavoni C, Intermesoli T, Spinelli O, Tosi M, Audisio E, Marmont F, Cattaneo C, Borlenghi E, Cortelazzo S, Cavattoni I, Fumagalli M, Mattei D, Romani C, Cortelezzi A, Fracchiolla N, Ciceri F, Bernardi M, Scattolin AM, Depaoli L, Masciulli A, Oldani E, Rambaldi A. Updated risk-oriented strategy for acute lymphoblastic leukemia in adult patients 18–65 years: NILG ALL 10/07. Blood Cancer Journal. 2020;10:119. doi: 10.1038/s41408-020-00383-2. - DOI - PMC - PubMed